Skip to main content
Medical Data Vision Co.,Ltd. logo

Medical Data Vision Co.,Ltd. — Investor Relations & Filings

Ticker · 3902 ISIN · JP3921250001 T Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 74 across all filing types
Latest filing 2023-11-13 Report Publication Anno…
Country JP Japan
Listing T 3902

About Medical Data Vision Co.,Ltd.

https://en.mdv.co.jp/

Medical Data Vision Co., Ltd. (MDV) is a healthcare data provider that operates one of the largest medical databases in its market. The company aggregates and processes real-world administrative data from hundreds of hospitals, encompassing records for over 50 million patients. This database provides detailed insights into treatment patterns, patient conditions, and medication decision-making. MDV offers data and analytical services primarily to pharmaceutical companies, medical device manufacturers, and research institutions for use in research, development, and market analysis. Additionally, the company provides information and communication technology (ICT) solutions and management support systems for medical institutions.

Recent filings

Filing Released Lang Actions
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, specifically related to the accuracy of a Quarterly Report (第3四半期報告書). While it references a quarterly report, the document itself is a regulatory confirmation statement filed with the Kanto Local Finance Bureau. Since it is a specific regulatory filing required by law that does not constitute the full financial report itself, it falls under the RNS (Regulatory Filings) category.
2023-11-13 Japanese
四半期報告書-第21期第3四半期(2023/07/01-2023/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan. It contains comprehensive financial statements, including the balance sheet, income statement, and comprehensive income statement for the third quarter of the fiscal year 2023. It also includes management's analysis of financial results and business conditions. This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. 9M 2023
2023-11-13 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under Article 24-4-8 of the Financial Instruments and Exchange Act of Japan, which accompanies a Quarterly Report (Shihanki Hokokusho). While it references the quarterly report, it is a formal regulatory filing confirming the accuracy of the financial statements for the second quarter. Given the specific regulatory nature and the fact that it is a standalone filing required by Japanese law to accompany the interim report, it falls under the category of Regulatory Filings (RNS).
2023-08-10 Japanese
四半期報告書-第21期第2四半期(2023/04/01-2023/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan, as indicated by the header and the regulatory reference (Financial Instruments and Exchange Act). It contains detailed financial statements, management analysis, and shareholding information for the second quarter of the fiscal year 2023. This fits the definition of an Interim/Quarterly Report (IR). H1 2023
2023-08-10 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under Article 24-4-8 of the Financial Instruments and Exchange Act, which accompanies a Quarterly Report (第1四半期報告書). Since this document is a formal regulatory filing confirming the accuracy of the quarterly report and is not the quarterly report itself, it falls under the category of general regulatory filings.
2023-05-12 Japanese
四半期報告書-第21期第1四半期(2023/01/01-2023/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '第1四半期報告書' (First Quarter Report) for Medical Data Vision Co., Ltd., covering the period from January 1, 2023, to March 31, 2023. It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement, as well as notes to the financial statements. This meets the criteria for an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. Q1 2023
2023-05-12 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.